IP Library Granted Patent US 12,372,516
Granted Patent B2
US 12,372,516 · App. 17/778,332 · Granted Jul 29, 2025

Methods and compositions for lateral flow analyte assays

Inventors: William Patrick Coffey (Carlsbad, CA); Gregory Reneff (Carlsbad, CA); Ezra John Spencer (Carlsbad, CA)
Assignee: IVD VISION, LLC
G01N33/52B01L3/5023G01N21/78G01N33/54388B01L2200/12B01L2200/148B01L2300/0654B01L2300/0825G01N2021/7759
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,372,516
App. No.
17/778,332
Granted
Jul 29, 2025
Kind
B2
Abstract

It is an object of the present invention to provide improved lateral flow test devices that can provide sensitive and accurate quantitative test results, and methods for the manufacture thereof.

Claims (37)

1. A lateral flow analyte test device comprising:

(a) a test strip comprising:

a first bibulous material defining a sample receiving region;

a second bibulous material defining an absorbent region; and

a porous membrane comprising:

at least one test zone comprising one or more reagents;

a proximal end and a distal end;

a first lateral edge and a second lateral edge;

a first length defined from the proximal end to the distal end and a first width defined from the first lateral edge to the second lateral edge wherein the first length is perpendicular to the first width; and

a porous membrane surface defined by the first length and the first width to the first length, wherein the first bibulous material is disposed at the proximal end, the second bibulous material is disposed at the distal end, the first bibulous material and the second bibulous material are fluidically connected to the porous membrane, the porous membrane is configured to enable a sample applied to the sample receiving region to traverse from the proximal end to the distal end, and the at least one test zone is configured to bind at least one analyte of interest from the sample and immobilize the at least one analyte of interest at the at least one test zone, the at least one test zone having a second width defined along the first width and a second length defined along the first length;

(b) a substantially rigid base supporting the test strip;

(c) a circuit board comprising:

at least one light source configured to illuminate the at least one test zone with electromagnetic radiation, and

at least one photodetector configured to detect one or more optical signals from the at least one test zone illuminated by the at least one light source;

(d) a circuit board support comprising:

a first aperture having a first end proximal to the at least one light source and a second end a second end proximal to the at least one test zone; and

a second aperture, wherein the circuit board is configured to (i) position the at least one light source above the at least one test zone at a first height location lateral to the first width, and to (ii) position the at least one photodetector above the at least one test zone at a second height location approximately centered on the first width wherein the first aperture is elongate and is configured to enable electromagnetic radiation from the light source disposed at the first height to illuminate the at least one test zone at an incidence angle between about 40° and about 10° relative to a line perpendicular to the porous membrane surface and wherein the second aperture is disposed between the at least one test zone and the at least one photodetector, and is configured to limit a view angle for the at least one photodetector to a porous membrane area including the at least one test zone and comprising less than twice an area range equivalent to the at least one test zone;

(e) a processor operably connected to the at least one light source and to the at least one photodetector and configured to:

(i) control illumination of the at least one test zone by the at least one light source,

(ii) receive an electrical signal from the at least one photodetector based on the one or more optical signals, and

(iii) convert the electrical signal into an assay result signal indicative of a presence or of an amount of the at least one analyte of interest in the sample; and

(f) a display operably connected to the processor and configured to receive the assay result signal from the processor and to display an assay result based on the assay result signal.

2. The lateral flow analyte test device according to claim 1 wherein the one or more optical signals detected from the at least one test zone by the at least one photodetector is defined by: 1-[(a run-time optical signal)−(an offset signal)]/[(a reference signal)−(the offset signal)], wherein the run-time optical signal is one or more optical signals measured in a test run; the reference signal is measured from a given measurement zone; the reference signal is an optical signal measured from a corresponding lateral flow analyte test device unreacted with a sample; and the offset signal is an optical signal measured from a corresponding lateral flow analyte test device having a porous membrane having a material absorbing at least 90% of electromagnetic radiation emitted from the at least one light source.

3. The lateral flow analyte test device according to claim 2 wherein the assay result is a quantitative result.

4. The lateral flow analyte test device according to claim 3 wherein the amount of the at least one analyte of interest in the sample is measured based on a change in absorbance or based on a change in fluorescence of electromagnetic radiation emitted by the light source and incident on the at least one test zone.

5. The lateral flow analyte test device according to claim 1 wherein the porous membrane area is defined by a sampling width, and a sampling length wherein the sampling width is less than 1.5 times the first width and the sampling length is less than 1.5 times the first length.

6. The lateral flow analyte test device according to claim 1 wherein the porous membrane area is defined by a sampling width, and a sampling length wherein the sampling width is less 1.9 times the first width and the sampling length is less than 1.1 times the first length.

7. The lateral flow analyte test device according to claim 1 wherein the second aperture is configured to prevent light not emanating from the test strip from impinging on the at least one photodetector.

8. The lateral flow analyte test device according to claim 1 wherein the first aperture, the light source, the second aperture and the at least one photodetector are configured to prevent incident light reflecting off of the test strip from impinging into the at least one photodetector.

9. The lateral flow analyte test device according to claim 1 , wherein the first bibulous material or the porous membrane comprises a labeled mobilizable reagent for binding to the at least one analyte of interest, and wherein the labeled mobilizable reagent and the at least one analyte of interest can form sandwich complexes with the one or more reagents.

10. The lateral flow analyte test device according to claim 1 wherein the first bibulous material or the porous membrane comprises a labeled mobilizable reagent for competing with the at least one analyte of interest to bind to the one or more reagents.

11. The lateral flow analyte test device according to claim 9 wherein the labeled mobilizable reagent comprises a metal colloid label.

12. The lateral flow analyte test device according to claim 9 wherein the labeled mobilizable reagent comprises a particulate label.

13. The lateral flow analyte test device according to claim 9 wherein the labeled mobilizable reagent comprises a fluorescent label.

14. The lateral flow analyte test device according to claim 10 wherein the labeled mobilizable reagent comprises a metal colloid label.

15. The lateral flow analyte test device according to claim 10 wherein the labeled mobilizable reagent comprises a particulate label.

16. The lateral flow analyte test device according to claim 10 wherein the labeled mobilizable reagent comprises a fluorescent label.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2022
From: COFFEY, WILLIAM PATRICK; SPENCER, EZRA JOHN; RENEFF, GREGORY
To: IVD VISION, LLC
Reel/Frame 059963/0122 →
Continuity (2)
Provisional Application 62937652 · Nov 19, 2019
Related Publication 20230003722A1 · Jan 5, 2023
References Cited (54)
US 4703017A · Campbell et al. · 1987 [cited by applicant]
US 4743560A · Campbell et al. · 1988 [cited by applicant]
US 4942522A · Wilkie et al. · 1990 [cited by applicant]
US 4956302A · Gordon et al. · 1990 [cited by applicant]
US 5028139A · Kramer · 1991 [cited by examiner]
US 5073484A · Swanson et al. · 1991 [cited by applicant]
US 5120643A · Ching et al. · 1992 [cited by applicant]
US 5252496A · Kang et al. · 1993 [cited by applicant]
US 5559041A · Kang et al. · 1996 [cited by applicant]
US 5580794A · Allen · 1996 [cited by applicant]
US 5591645A · Rosenstein · 1997 [cited by applicant]
US 5602040A · May et al. · 1997 [cited by applicant]
US 5622871A · May et al. · 1997 [cited by applicant]
US 5654162A · Guire et al. · 1997 [cited by applicant]
US 5656448A · Kang et al. · 1997 [cited by applicant]
US 5656503A · May et al. · 1997 [cited by applicant]
US 5714389A · Charlton et al. · 1998 [cited by applicant]
US 5728587A · Kang et al. · 1998 [cited by applicant]
US 5989921A · Charlton et al. · 1999 [cited by applicant]
US 6020147A · Guire et al. · 2000 [cited by applicant]
US 6027943A · Kang et al. · 2000 [cited by applicant]
US 6187598B1 · May et al. · 2001 [cited by applicant]
US 6228660B1 · May et al. · 2001 [cited by applicant]
US 6352862B1 · Davis et al. · 2002 [cited by applicant]
US 6394952B1 · Anderson et al. · 2002 [cited by applicant]
US 6485982B1 · Charlton · 2002 [cited by applicant]
US 6506612B2 · Kang et al. · 2003 [cited by applicant]
US 6534320B2 · Ching et al. · 2003 [cited by applicant]
US 6541277B1 · Kang et al. · 2003 [cited by applicant]
US RE38430E · Rosenstein · 2004 [cited by applicant]
US 6737277B1 · Kang et al. · 2004 [cited by applicant]
US 6818455B2 · May et al. · 2004 [cited by applicant]
US 7141212B2 · Catt et al. · 2006 [cited by applicant]
US 7763454B2 · Nazareth et al. · 2010 [cited by applicant]
US 9222875B2 · Egan et al. · 2015 [cited by applicant]
US 20010008774A1 · May et al. · 2001 [cited by applicant]
US 20030143755A1 · Davis et al. · 2003 [cited by applicant]
US 20030207465A1 · Davis et al. · 2003 [cited by applicant]
US 20030219908A1 · Davis et al. · 2003 [cited by applicant]
US 20050244986A1 · May et al. · 2005 [cited by applicant]
US 20060008896A1 · Nazareth et al. · 2006 [cited by applicant]
US 20060040405A1 · Charlton et al. · 2006 [cited by applicant]
US 20060240541A1 · Petruno · 2006 [cited by examiner]
US 20110223673A1 · Profitt · 2011 [cited by examiner]
US 20130280696A1 · Millenson et al. · 2013 [cited by applicant]
US 20180246038A1 · Hunter · 2018 [cited by examiner]
US 20200072722A1 · Ryu · 2020 [cited by examiner]
EP 0653625A1 · 1995 [cited by applicant]
EP 0833145A1 · 1998 [cited by applicant]
GB 2569554A1 · 2019 [cited by applicant]
International Search Report and Written Opinion issued in PCT/US2020/061344 on Mar. 26, 2021 (11 pages). [cited by applicant]
International Search Report issued in PCT/US2020/061344 dated Mar. 26, 2021 (11 pages). [cited by applicant]
International Preliminary Report on Patentability issued in PCT/US2020/061344 dated Jun. 2, 2022 (8 pages). [cited by applicant]
Extended European Search Report issued in EP 20890587.7 dated Feb. 6, 2024 (14 pages). [cited by applicant]